Lee Delaney died Thursday, the company said. In the wake of his passing, chief administrative and financial officer Bob Eddy will serve as interim CEO.
Organon, a proposed spinoff of Merck's women's health, biosimilars and established brands businesses, intends to appoint a majority-female board of directors.
